0 оценок0% нашли этот документ полезным (0 голосов)
3 просмотров13 страниц
Psoriasis is a chronic skin condition that often causes arthritis and can develop at any age, though most commonly between 15-30 years old. It has a multifactorial genetic component and can be exacerbated by stressful life events, infections, and environmental factors. Psoriasis is an immune-mediated disease where cytokines, dendritic cells, and T lymphocytes in skin lesions have led to new biologic therapies, though the specific immunogen remains unknown.
Psoriasis is a chronic skin condition that often causes arthritis and can develop at any age, though most commonly between 15-30 years old. It has a multifactorial genetic component and can be exacerbated by stressful life events, infections, and environmental factors. Psoriasis is an immune-mediated disease where cytokines, dendritic cells, and T lymphocytes in skin lesions have led to new biologic therapies, though the specific immunogen remains unknown.
Psoriasis is a chronic skin condition that often causes arthritis and can develop at any age, though most commonly between 15-30 years old. It has a multifactorial genetic component and can be exacerbated by stressful life events, infections, and environmental factors. Psoriasis is an immune-mediated disease where cytokines, dendritic cells, and T lymphocytes in skin lesions have led to new biologic therapies, though the specific immunogen remains unknown.
Psoriasis is a chronic skin condition that is often associated with
systemic manifestations, especially arthritis Psoriasis can develop at any age Onset is most likely between 15 and 30 years of age Risk Factor and Etiologi
Research suggests a multifactorial mode of inheritance
Many stressful physiologic and psychological events and environmental factors are associated with the onset and worsening of the condition. Many infection can exacerbate exiting psoriasis Pathophysiology
Psoriasis is an immune-mediated disease with genetic
predisposition, but no distinct immunogen has been identified. The presence of cytokines, dendritic cells, and T lymphocytes in psoriatic lesions has prompted the development of biologic therapies. Clinical Features and Classification